Calidi Biotherapeutics (CLDI) Exchange Rate Effect (2022 - 2025)
Calidi Biotherapeutics (CLDI) posted quarterly Exchange Rate Effect of $8000.0 for Q4 2025, down 50.0% year-over-year from $16000.0 in Q4 2024, and down 50.0% quarter-over-quarter from $16000.0 in Q4 2024.
Calidi Biotherapeutics (CLDI) Exchange Rate Effect (2022 - 2025) Analysis & Trends
Calidi Biotherapeutics' Exchange Rate Effect history runs 4 years deep, the most recent figure standing at $8000.0 for Q4 2025.
- In Q4 2025, Exchange Rate Effect fell 50.0% year-over-year to $8000.0; the TTM figure through Dec 2025 stood at -$9000.0 (up 30.77% YoY), while the FY2025 annual figure was $14000.0, up 207.69% from the prior year.
- Exchange Rate Effect for Q4 2025 stood at $8000.0, down from $16000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $23000.0 in Q3 2023, with the low at -$33000.0 in Q3 2024.
- The 4-year median for Exchange Rate Effect is $8000.0 (2022), against an average of $875.0.
- The sharpest annual moves came in 2023 and 2024: Exchange Rate Effect sank 337.5% in 2023, then jumped 184.21% in 2024.
- Calidi Biotherapeutics' Exchange Rate Effect stood at $8000.0 in 2022, then tumbled by 337.5% to -$19000.0 in 2023, then surged by 184.21% to $16000.0 in 2024, then slumped by 50.0% to $8000.0 in 2025.
- Business Quant data shows CLDI's Exchange Rate Effect at $8000.0 in Q4 2025, $16000.0 in Q4 2024, and -$33000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.45 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -287,000.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.63 Mn |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8,000.00 |
| Dec 31, 2025 | 8,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Sep 30, 2024 | -33,000.00 |
| Sep 30, 2024 | -33,000.00 |
| Jun 30, 2024 | -13,000.00 |
| Jun 30, 2024 | -13,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | -19,000.00 |
| Dec 31, 2023 | -19,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Dec 31, 2022 | 8,000.00 |